Make some medications more affordable by cutting one piece of red tape
Summary
The article urges Congress to pass the Biosimilar Red Tape Elimination Act. It says the bill would lower medication costs by removing the interchangeability standard for biologic medicines.Key Facts
- The article supports passage of the Biosimilar Red Tape Elimination Act.
- The bill concerns biologic medicines and biosimilars.
- The proposal would remove the interchangeability standard for biosimilars.
- The article says the standard adds costs.
- The article argues that removing the standard could make medications more affordable.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
